These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 1621894)

  • 1. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
    Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
    Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.
    Collins WE; Anders RF; Ruebush TK; Kemp DJ; Woodrow GC; Campbell GH; Brown GV; Irving DO; Goss N; Filipski VK
    Am J Trop Med Hyg; 1991 Jan; 44(1):34-41. PubMed ID: 1996739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
    Cavanagh DR; Kocken CH; White JH; Cowan GJ; Samuel K; Dubbeld MA; Voorberg-van der Wel A; Thomas AW; McBride JS; Arnot DE
    PLoS One; 2014; 9(1):e83704. PubMed ID: 24421900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
    Chang SP; Case SE; Gosnell WL; Hashimoto A; Kramer KJ; Tam LQ; Hashiro CQ; Nikaido CM; Gibson HL; Lee-Ng CT; Barr PJ; Yokota BT; Hut GS
    Infect Immun; 1996 Jan; 64(1):253-61. PubMed ID: 8557348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO; Keegan B; Long CA; Miller LH
    J Infect Dis; 2006 Mar; 193(5):731-40. PubMed ID: 16453270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys.
    Herrera S; Herrera MA; Certa U; Corredor A; Guerrero R
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():423-8. PubMed ID: 1343722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK
    J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.
    Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE
    Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens.
    Ruebush TK2nd ; Campbell GH; Moreno A; Patarroyo ME; Collins WE
    Am J Trop Med Hyg; 1990 Oct; 43(4):355-66. PubMed ID: 2240363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection.
    Burghaus PA; Wellde BT; Hall T; Richards RL; Egan AF; Riley EM; Ballou WR; Holder AA
    Infect Immun; 1996 Sep; 64(9):3614-9. PubMed ID: 8751907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant.
    Inselburg J; Bathurst IC; Kansopon J; Barr PJ; Rossan R
    Infect Immun; 1993 May; 61(5):2048-52. PubMed ID: 8478093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.
    Hui GS; Nikaido C; Hashiro C; Kaslow DC; Collins WE
    Infect Immun; 1996 May; 64(5):1502-9. PubMed ID: 8613353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA; Maris DC; Doolan D; Charoenvit Y; Obaldia N; Rossan R; Sedegah M; Wang R; Hobart P; Margalith M; Hoffman S
    Vaccine; 1997 Jun; 15(8):913-5. PubMed ID: 9234546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of different strains of Plasmodium falciparum for testing blood-stage vaccines in Aotus nancymai monkeys.
    Collins WE; Galland GG; Sullivan JS; Morris CL
    Am J Trop Med Hyg; 1994 Aug; 51(2):224-32. PubMed ID: 8074257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
    Egan AF; Blackman MJ; Kaslow DC
    Infect Immun; 2000 Mar; 68(3):1418-27. PubMed ID: 10678955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.
    Siddiqui WA; Tam LQ; Kramer KJ; Hui GS; Case SE; Yamaga KM; Chang SP; Chan EB; Kan SC
    Proc Natl Acad Sci U S A; 1987 May; 84(9):3014-8. PubMed ID: 3554251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.